Publicação

Novel 3+1 mixed-ligand Technetium-99m complexes carrying dipeptides as monodentate ligands

Ver documento

Detalhes bibliográficos
Resumo:Novel mixed ligand oxotechnetium complexes of the type [(TcO)-Tc-99m(SSS)(SR)], in which the SR monodentate ligand is derived from dipeptides gly-gly, phe-gly and ala-gly, have been synthesized. These complexes, which have a molecular weight above 300, a lipophilic moiety, [TcO(SSS)](+), and an ionizable group separated from the lipophilic moiety by a spacer, have been obtained in 70-95% radiochemical yield. These compounds were prepared using Tc-99m-tartrate as the precursor and Sn2+ as the reducing agent. The identity of the [(TcO)-Tc-99m(SSS)(SR)] complexes has been established by HPLC comparison with the analogous oxorhenium complexes. The nature of the monodentate co-ligand strongly affects the stability of the Tc-99m-complexes and their biodistribution. Complex 3b is the most stable in vitro presenting the highest blood clearance, a high liver uptake and a selective hepatobiliary excretion (54.5% ID at 15 min post-injection, and 69.3% ID at 60 min post injection). The results obtained show that 3b have reasonable stability and in vivo properties that may be useful for peptide labeling. (C) 2004 Elsevier Inc. All rights reserved.
Autores principais:Fernandes, C
Outros Autores:Patricio, L; Moreira, R; Cantinho, G; Pena, H; Campello, PC; Santos, I
Assunto:Radiology, Nuclear Medicine & Medical Imaging
Ano:2004
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso a metadados
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
Descrição
Resumo:Novel mixed ligand oxotechnetium complexes of the type [(TcO)-Tc-99m(SSS)(SR)], in which the SR monodentate ligand is derived from dipeptides gly-gly, phe-gly and ala-gly, have been synthesized. These complexes, which have a molecular weight above 300, a lipophilic moiety, [TcO(SSS)](+), and an ionizable group separated from the lipophilic moiety by a spacer, have been obtained in 70-95% radiochemical yield. These compounds were prepared using Tc-99m-tartrate as the precursor and Sn2+ as the reducing agent. The identity of the [(TcO)-Tc-99m(SSS)(SR)] complexes has been established by HPLC comparison with the analogous oxorhenium complexes. The nature of the monodentate co-ligand strongly affects the stability of the Tc-99m-complexes and their biodistribution. Complex 3b is the most stable in vitro presenting the highest blood clearance, a high liver uptake and a selective hepatobiliary excretion (54.5% ID at 15 min post-injection, and 69.3% ID at 60 min post injection). The results obtained show that 3b have reasonable stability and in vivo properties that may be useful for peptide labeling. (C) 2004 Elsevier Inc. All rights reserved.